Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Alzheimer Disease and Associated Disorders is Scopus-indexed (Q2, CiteScore 2.7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 0893-0341Verify ISSN ↗1546-4156Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Clinical Psychology | 151 / 314 | 52nd | Q2 |
| Psychiatry and Mental Health | 322 / 580 | 44th | Q3 |
| Gerontology | 23 / 40 | 43rd | Q3 |
| Geriatrics and Gerontology | 80 / 123 | 35th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1987–present, best quartile Q2, CiteScore 2.7.
Alzheimer Disease and Associated Disorders is Q2 in Clinical Psychology (rank 151 of 314), Q3 in Psychiatry and Mental Health (rank 322 of 580) and Q3 in Gerontology (rank 23 of 40), by CiteScore 2025. It is ranked in 4 subject areas in all.
Alzheimer Disease and Associated Disorders is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.7, which places it in quartile Q2 at the 52nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.485, quartile Q2, with an H-index of 116.
Alzheimer Disease and Associated Disorders is published by Lippincott Williams and Wilkins. Its print ISSN is 0893-0341 and its online ISSN is 1546-4156.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Alzheimer Disease and Associated Disorders has an h-index of 131 and a 2-year mean of 1.52 citations per paper (OpenAlex). Its Scopus CiteScore is 2.7, quartile Q2. On 2-year citations it ranks #121 of 308 Scopus journals in Clinical Psychology.
Alzheimer Disease and Associated Disorders published 56 papers in 2025; its busiest recent year was 2019 with 78. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2024–2026), authors are most often from United States (41.7%), Japan (8.5%) and China (7.2%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.